Impact of Seton Use on Clinical, Patient-Reported, and Healthcare Resource Utilization Outcomes in Complex Crohn's Perianal Fistulas: A Systematic Literature Review.

Inflamm Bowel Dis · 2025 · PMC12166306 · PMID 39298676

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an overall trendno p-value reported

Although results were heterogeneous, we did observe an overall trend of improved outcomes in patients who receive seton with IFX or other biologics when compared with those receiving seton treatment only.

also in 4,871 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.